Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare May Require Part D Plans To Provide Point-of-Sale Rebates

Executive Summary

CMS outlines possible approach to point-of-sale rebates in Medicare Part D, recognizing that using rebates to lower cost sharing for 'many' would increase premiums for all.

You may also be interested in...



Part D Rebates: Policy Tweak Would Retain Manufacturer ‘Contributions’

Peter Bach’s new approach to calculating TrOOP cost in Medicare would prevent big savings to manufacturers from point-of-sale rebates.

Medicare Part D Rule Offers Modest Drug Price Savings, No Point-of-Sale Rebates

CMS Administrator Verma declined to suggest a timeframe for when such a policy redirecting negotiated drug rebates to offset cost sharing in Medicare Part D might be implemented.

Impact Of Rebates On Drug Pricing Will Diminish -- CMS Experts

Actuaries with the US Centers for Medicare and Medicaid Services predict the share of retail prescription drug costs represented by manufacturer rebates will level off in the coming years, resulting in higher drug pricing trends across government and commercial insurance.

Related Content

Topics

UsernamePublicRestriction

Register

PS121991

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel